Merrithew & Thorsten »

Ligand Pharmaceuticals In shares owned by Merrithew & Thorsten

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Merrithew & Thorsten from 13F filings

Historical chart of Merrithew & Thorsten investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Merrithew & Thorsten consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Merrithew & Thorsten

Quarter filed Position value Share count Share price at filing
2026-03-31 $25k 129 193.80

More positions owned by Merrithew & Thorsten

Vanguard Index Fds S&p 500 Etf Shs (VOO)
PIMCO Corporate Opportunity Fund (PTY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard World Consum Dis Etf (VCR)
Vanguard World Consum Stp Etf (VDC)
Prologis (PLD)
Realty Income (O)
Oracle Corporation (ORCL)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Caterpillar (CAT)
Vanguard Index Fds Small Cp Etf (VB)
Ball Corporation (BALL)
Microsoft Corporation (MSFT)

View all positions for Merrithew & Thorsten

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Vanguard Portfolio Management
Henderson Group
Vanguard Capital Management
Invesco
State Street Corporation
FMR
Nomura Asset Management International
Franklin Resources
Chicago Capital
Geode Capital Management
Massachusetts Financial Services
Congress Asset Management
Stephens Investment Management Group

View all funds holding Ligand Pharmaceuticals In